SEC Form 4 · accession 0001232524-17-000119
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rick E Winningham
Director
Period of report
Jun 1, 2017
Accepted (ET)
Jun 2, 2017 · 6:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jun 1, 2017 | S | 5,000 | $150.00 | D | 10,391 | D |
Table II — derivative securities
No Table II lines on this filing.